No, cefepime and cefixime do NOT cover the same organisms
Cefepime and cefixime have fundamentally different antimicrobial spectra and clinical applications. While both are cephalosporins, cefepime is a fourth-generation parenteral agent with broad gram-negative coverage including Pseudomonas aeruginosa, whereas cefixime is a third-generation oral agent that lacks anti-pseudomonal activity.
Key Differences in Organism Coverage
Cefepime (Fourth-Generation, IV)
According to FDA labeling, cefepime demonstrates activity against 1:
Gram-negative organisms:
- Pseudomonas aeruginosa (critical difference)
- Enterobacter spp
- E. coli
- Klebsiella pneumoniae
- Proteus mirabilis
- Extended coverage against AmpC-producing organisms 2, 3
Gram-positive organisms:
- Methicillin-susceptible Staphylococcus aureus (MSSA)
- Streptococcus pneumoniae
- Streptococcus pyogenes
- Viridans group streptococci
Notable resistance: Enterococci, MRSA, and Stenotrophomonas maltophilia 1
Cefixime (Third-Generation, Oral)
Cefixime has a narrower spectrum 4:
Gram-negative organisms:
- E. coli
- Klebsiella spp
- Proteus mirabilis
- Haemophilus influenzae
- Moraxella catarrhalis
- NO activity against Pseudomonas aeruginosa (critical difference)
Gram-positive organisms:
- Streptococcus pyogenes
- Streptococcus pneumoniae
- Limited activity against staphylococci
Clinical Application Differences
When to Use Cefepime
Multiple guidelines recommend cefepime for 5, 2, 6:
- Febrile neutropenia (empiric monotherapy)
- Hospital-acquired infections requiring anti-pseudomonal coverage
- Severe intra-abdominal infections (with metronidazole for anaerobes) 2, 3
- Healthcare-associated infections with risk of resistant gram-negatives
- Empyema requiring broad coverage 7
When to Use Cefixime
Cefixime is appropriate for 4:
- Uncomplicated gonorrhea (though resistance emerging) 8, 9
- Uncomplicated urinary tract infections
- Acute otitis media in children
- Upper respiratory tract infections (pharyngitis, tonsillitis)
- Community-acquired infections without risk of Pseudomonas
Critical Clinical Pitfalls
Do not substitute cefixime for cefepime when:
- Anti-pseudomonal coverage is required
- Treating hospital-acquired infections
- Managing febrile neutropenia
- Treating severe infections requiring parenteral therapy
- AmpC-producing organisms are suspected
The route of administration matters: Cefepime is IV/IM only; cefixime is oral only. This fundamentally limits their interchangeability regardless of spectrum 1, 4.
Resistance Considerations
Cefepime maintains activity against many organisms resistant to third-generation cephalosporins due to its low affinity for chromosomally-encoded beta-lactamases and resistance to AmpC induction 1, 10. Cefixime lacks this advantage and has documented increasing resistance among E. coli and N. gonorrhoeae 8, 9.
Bottom line: These are not interchangeable agents. Cefepime provides hospital-grade, broad-spectrum coverage including Pseudomonas, while cefixime is an oral agent for community-acquired infections without anti-pseudomonal activity.